These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 9259265)

  • 1. The survival motor neuron protein in spinal muscular atrophy.
    Coovert DD; Le TT; McAndrew PE; Strasswimmer J; Crawford TO; Mendell JR; Coulson SE; Androphy EJ; Prior TW; Burghes AH
    Hum Mol Genet; 1997 Aug; 6(8):1205-14. PubMed ID: 9259265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between severity and SMN protein level in spinal muscular atrophy.
    Lefebvre S; Burlet P; Liu Q; Bertrandy S; Clermont O; Munnich A; Dreyfuss G; Melki J
    Nat Genet; 1997 Jul; 16(3):265-9. PubMed ID: 9207792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels.
    Wolstencroft EC; Mattis V; Bajer AA; Young PJ; Lorson CL
    Hum Mol Genet; 2005 May; 14(9):1199-210. PubMed ID: 15790598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.
    Monani UR; Sendtner M; Coovert DD; Parsons DW; Andreassi C; Le TT; Jablonka S; Schrank B; Rossoll W; Prior TW; Morris GE; Burghes AH
    Hum Mol Genet; 2000 Feb; 9(3):333-9. PubMed ID: 10655541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMN protein analysis in fibroblast, amniocyte and CVS cultures from spinal muscular atrophy patients and its relevance for diagnosis.
    Patrizi AL; Tiziano F; Zappata S; Donati MA; Neri G; Brahe C
    Eur J Hum Genet; 1999 Apr; 7(3):301-9. PubMed ID: 10234506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs.
    Gabanella F; Butchbach ME; Saieva L; Carissimi C; Burghes AH; Pellizzoni L
    PLoS One; 2007 Sep; 2(9):e921. PubMed ID: 17895963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons?
    Rossoll W; Kröning AK; Ohndorf UM; Steegborn C; Jablonka S; Sendtner M
    Hum Mol Genet; 2002 Jan; 11(1):93-105. PubMed ID: 11773003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III.
    Jablonka S; Schrank B; Kralewski M; Rossoll W; Sendtner M
    Hum Mol Genet; 2000 Feb; 9(3):341-6. PubMed ID: 10655542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells.
    Boda B; Mas C; Giudicelli C; Nepote V; Guimiot F; Levacher B; Zvara A; Santha M; LeGall I; Simonneau M
    Eur J Hum Genet; 2004 Sep; 12(9):729-37. PubMed ID: 15162126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
    J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a gene therapy strategy for the restoration of survival motor neuron protein expression: implications for spinal muscular atrophy therapy.
    DiDonato CJ; Parks RJ; Kothary R
    Hum Gene Ther; 2003 Jan; 14(2):179-88. PubMed ID: 12614569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy.
    Monani UR; Pastore MT; Gavrilina TO; Jablonka S; Le TT; Andreassi C; DiCocco JM; Lorson C; Androphy EJ; Sendtner M; Podell M; Burghes AH
    J Cell Biol; 2003 Jan; 160(1):41-52. PubMed ID: 12515823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy.
    Burlet P; Huber C; Bertrandy S; Ludosky MA; Zwaenepoel I; Clermont O; Roume J; Delezoide AL; Cartaud J; Munnich A; Lefebvre S
    Hum Mol Genet; 1998 Nov; 7(12):1927-33. PubMed ID: 9811937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel association of the SMN protein with two major non-ribosomal nucleolar proteins and its implication in spinal muscular atrophy.
    Lefebvre S; Burlet P; Viollet L; Bertrandy S; Huber C; Belser C; Munnich A
    Hum Mol Genet; 2002 May; 11(9):1017-27. PubMed ID: 11978761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts.
    Mattis VB; Rai R; Wang J; Chang CW; Coady T; Lorson CL
    Hum Genet; 2006 Nov; 120(4):589-601. PubMed ID: 16951947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of the porcine (Sus scrofa) survival motor neuron (SMN1) gene: an animal model for therapeutic studies.
    Lorson MA; Spate LD; Prather RS; Lorson CL
    Dev Dyn; 2008 Aug; 237(8):2268-78. PubMed ID: 18651653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of survival motor neuron (SMN) and neuronal apoptosis inhibitory protein (NAIP) genes of spinal muscular atrophy patients and their parents.
    Chang JG; Jong YJ; Lin SP; Soong BW; Tsai CH; Yang TY; Chang CP; Wang WS
    Hum Genet; 1997 Oct; 100(5-6):577-81. PubMed ID: 9341874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy.
    Sun Y; Grimmler M; Schwarzer V; Schoenen F; Fischer U; Wirth B
    Hum Mutat; 2005 Jan; 25(1):64-71. PubMed ID: 15580564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of survival motor neuron as a transcriptional activator-binding protein.
    Strasswimmer J; Lorson CL; Breiding DE; Chen JJ; Le T; Burghes AH; Androphy EJ
    Hum Mol Genet; 1999 Jul; 8(7):1219-26. PubMed ID: 10369867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for polyproline motifs in the spinal muscular atrophy protein SMN. Profilins bind to and colocalize with smn in nuclear gems.
    Giesemann T; Rathke-Hartlieb S; Rothkegel M; Bartsch JW; Buchmeier S; Jockusch BM; Jockusch H
    J Biol Chem; 1999 Dec; 274(53):37908-14. PubMed ID: 10608857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.